PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug test aims to heal painful, Hard-to-Treat skin wounds
Disease control Recruiting nowThis study is testing whether a medication called guselkumab can help heal painful skin ulcers caused by pyoderma gangrenosum, a rare inflammatory skin condition. Seventeen adult participants will receive guselkumab injections every four weeks along with a stable daily dose of pr…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to heal painful, Hard-to-Treat skin wounds
Disease control Recruiting nowThis study is testing if an intravenous medicine called spesolimab can help close painful skin ulcers caused by pyoderma gangrenosum, a rare inflammatory skin condition. It will involve about 90 adults with active ulcers, comparing spesolimab against a placebo infusion over about…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC